<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> used to treat <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) in East China </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A retrospective review was conducted, involving 227 patients with IBD admitted to Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University from June 2000 to December 2007 </plain></SENT>
<SENT sid="2" pm="."><plain>Data regarding demographic, clinical characteristics and <z:chebi fb="1" ids="35705">immunosuppressants</z:chebi> usage were analyzed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A total of 227 eligible patients were evaluated in this study, including 104 patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and 123 with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Among the patients, 61 had indications for <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> use </plain></SENT>
<SENT sid="5" pm="."><plain>However, only 21 (34.4%) received <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Among the 21 patients, 6 (37.5%) received a subtherapeutic dose of <z:chebi fb="2" ids="2948">azathioprine</z:chebi> with no attempt to increase the dosage </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 20 patients that received <z:chebi fb="1" ids="35705">immunosuppressive agent</z:chebi> treatment longer than 6 mo, 15 patients went into remission, four patients were not affected and one relapsed </plain></SENT>
<SENT sid="8" pm="."><plain>Among these 20 patients, four patients suffered from myelotoxicity and one suffered from <z:e sem="disease" ids="C0235378,C0348754" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">hepatotoxicity</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:chebi fb="1" ids="35705">Immunosuppressive agents</z:chebi> are used less frequently to treat IBD patients from East China compared with Western countries </plain></SENT>
<SENT sid="10" pm="."><plain>Monitoring <z:chebi fb="1" ids="35705">immunosuppressive agent</z:chebi> use is recommended to optimize dispensation of drugs for IBD in China </plain></SENT>
</text></document>